Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Oxid Med Cell Longev
2020 Jun 26;2020:7948705. doi: 10.1155/2020/7948705.
Show Gene links
Show Anatomy links
Antiproliferative Activity, Proapoptotic Effect, and Cell Cycle Arrest in Human Cancer Cells of Some Marine Natural Product Extract.
Cui H
,
Bashar MAE
,
Rady I
,
El-Naggar HA
,
Abd El-Maoula LM
,
Mehany ABM
.
???displayArticle.abstract???
Bioactive constituents of numerous marine organisms have been investigated recently for their preclinical and clinical anticancer activity. Three marine organisms: black-spotted sea cucumber: Pearsonothuria graeffei (Pg), lollyfish: Holothuria atra (Ha), and sea hare: Aplysia dactylomela (Ad), were collected during winter 2019 from Gulf of Aqaba, Red Sea, Egypt, and macerated with ethanol into three different extracts: PgE, HaE, and AdE, where each was in vitro assessed for its antiproliferative and proapoptotic properties on HepG2, HCT-116, and MCF-7 cancer cells. PgE dose-dependently inhibited the growth of HepG2, HCT-116, and MCF-7 cells within IC50 values 16.22, 13.34, and 18.09 μg/mL, respectively, while the IC50 values for the antiproliferative activity of HaE were 12.48, 10.45, and 10.36 μg/mL, respectively, and the IC50 values of AdE were 6.51, 5.33, and 6.87 μg/mL, respectively. All extracts were found to induce G0/G1 cell cycle arrest for HepG2 cells side by side with their inhibition of CDK2 on all three cell lines while all extracts were also showed to induce apoptosis in HepG2 cell line at pre-G 1 phase supplemented by their anticancer activity via proapoptotic protein Bax, caspase-3, and cleavage PARP increase, and antiapoptotic protein Bcl-2 downturn. Moreover, necrosis has been relatively noticed in HepG2 cell line as an additional anticancer activity for each extract. Our data introduced three ethanolic marine extracts as natural chemotherapeutic agents to be further developed for cancer control.
Figure 1. Antiproliferative activity of PgE, HaE, and AdE against HePG2, HCT-116, and MCF-7 cell lines.
Figure 2. Cell cycle analysis effect in HepG2 cells treated with PgE, HaE, and AdE.
Figure 3. Cell cycle analysis and apoptosis effect in HepG2 cell line treated with PgE, HaE, and AdE.
Figure 4. Modulation of CDK2 protein expression in HePG2, HCT-116, and MCF-7 cells was treated dose-dependently with PgE, HaE, and AdE and harvested 24âh after treatments. The immunoblots shown are representative of three independent experiments which all gave similar results where only representative result was cropped and inserted here. Bars represent the means ± SD. Single, double, triple, and quadruple asterisks are used for p < 0.05, p < 0.01, p < 0.001, and p < 0.0001, respectively, vs. control (DMSO-treated) cells.
Figure 5. Comparative modulation of Bax, Bcl-2, and caspase-3 protein expressions in HePG2 cells was treated with PgE, HaE, and AdE and harvested 24âh after treatments.
Figure 6. Modulation of the apoptotic protein biomarkers: PARP (116âkD) and cleaved PARP (85âkD) in HePG2, HCT-116, and MCF-7 cells, was treated dose-dependently with PgE, HaE, and AdE and harvested 24âh after treatments. The immunoblots shown are representative of three independent experiments which all gave similar results where the only representative result was cropped and inserted here. Bars represent the means ± SD. Single, double, triple, and quadruple asterisks are used for p < 0.05, p < 0.01, p < 0.001, and p < 0.0001, respectively, vs. control (DMSO-treated) cells.
Figure 7. Percentage of apoptosis and necrosis induced by PgE, HaE, and AdE in HepG2 cells.
Figure 8. Cell death percentage induced by PgE, HaE, and AdE in HepG2 cells.
Figure 9. Schematic drawing of the mechanism of action of PGE, HaE, and AdE on HepG2 cancer cells. This cartoon is based on the currently available data throughout the present study.
Figure 10. Taxonomical positions and photographs of Pg, Ha, and Ad.
Ammar,
Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity.
2018, Pubmed
Ammar,
Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity.
2018,
Pubmed
Chamcheu,
Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog Signaling.
2018,
Pubmed
Chari,
A phase II trial of TBL-12 sea cucumber extract in patients with untreated asymptomatic myeloma.
2018,
Pubmed
Chin,
Drug discovery from natural sources.
2006,
Pubmed
Cuvillier,
Sphingosine in apoptosis signaling.
2002,
Pubmed
Donia,
Marine natural products and their potential applications as anti-infective agents.
2003,
Pubmed
Du,
The anti-tumor activities of cerebrosides derived from sea cucumber Acaudina molpadioides and starfish Asterias amurensis in vitro and in vivo.
2012,
Pubmed
,
Echinobase
Faulkner,
Marine natural products.
2000,
Pubmed
Kariya,
Isolation and partial characterization of fucan sulfates from the body wall of sea cucumber Stichopus japonicus and their ability to inhibit osteoclastogenesis.
2004,
Pubmed
,
Echinobase
Kim,
Anti-Skin Cancer Activities of Apostichopus japonicus Extracts from Low-Temperature Ultrasonification Process.
2017,
Pubmed
,
Echinobase
Lo,
Luminescent biological probes derived from ruthenium(II) estradiol polypyridine complexes.
2008,
Pubmed
Pietra,
Secondary metabolites from marine microorganisms: bacteria, protozoa, algae and fungi. Achievements and prospects.
1997,
Pubmed
Rady,
Anticancer Properties of Graviola (Annona muricata): A Comprehensive Mechanistic Review.
2018,
Pubmed
Rady,
Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy.
2017,
Pubmed
Ruggiero,
A higher level classification of all living organisms.
2015,
Pubmed
Salimi,
Selective toxicity of persian gulf sea cucumber holothuria parva on human chronic lymphocytic leukemia b lymphocytes by direct mitochondrial targeting.
2017,
Pubmed
,
Echinobase
Sanna,
Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.
2017,
Pubmed
Tian,
PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
2005,
Pubmed
,
Echinobase
Tian,
Philinopside E, a new sulfated saponin from sea cucumber, blocks the interaction between kinase insert domain-containing receptor (KDR) and alphavbeta3 integrin via binding to the extracellular domain of KDR.
2007,
Pubmed
,
Echinobase
Tsuda,
Cancer prevention by natural compounds.
2004,
Pubmed
Wali,
Natural products against cancer: Review on phytochemicals from marine sources in preventing cancer.
2019,
Pubmed
Wang,
Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies.
2000,
Pubmed
Xu,
Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer.
2013,
Pubmed